Skip to Content

Haemophilus b conjugate (prp-omp) vaccine Pregnancy and Breastfeeding Warnings

Haemophilus b conjugate (prp-omp) vaccine is also known as: Liquid PedvaxHIB

Medically reviewed on December 8, 2017

Haemophilus b conjugate (prp-omp) vaccine Pregnancy Warnings

Haemophilus b conjugate (PRP-OMP) vaccine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are not data in human pregnancy. Haemophilus b conjugate (PRP-OMP) vaccine is not recommended for use in a pregnant woman and is not approved for use in children 6 years of age or older.

See references

Haemophilus b conjugate (prp-omp) vaccine Breastfeeding Warnings

There are no data on the excretion of haemophilus b conjugate (PRP-OMP) vaccine in human milk. Haemophilus b conjugate (PRP-OMP) vaccine is not approved for use in children 6 years of age or older.

See references

References for pregnancy information

  1. "Product Information. Liquid PedvaxHIB (haemophilus b conjugate (PRP-OMP) vaccine)." Merck & Company Inc, West Point, PA.

References for breastfeeding information

  1. "Product Information. Liquid PedvaxHIB (haemophilus b conjugate (PRP-OMP) vaccine)." Merck & Company Inc, West Point, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide